PhiChem Corporation
300398.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.27 | -1.00 | 1.84 | 0.47 |
| FCF Yield | 5.01% | 0.23% | 2.28% | -0.09% |
| EV / EBITDA | 16.24 | 19.78 | 13.54 | 21.49 |
| Quality | ||||
| ROIC | 5.00% | 2.37% | 7.91% | 8.30% |
| Gross Margin | 34.44% | 34.32% | 39.29% | 39.77% |
| Cash Conversion Ratio | 2.39 | 2.14 | 0.90 | 0.64 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.12% | 1.27% | 15.96% | 20.18% |
| Free Cash Flow Growth | 2,071.47% | -90.58% | 1,964.67% | 88.30% |
| Safety | ||||
| Net Debt / EBITDA | 0.69 | 1.40 | 0.59 | 1.10 |
| Interest Coverage | 5.69 | 2.24 | 7.28 | 6.15 |
| Efficiency | ||||
| Inventory Turnover | 2.88 | 2.77 | 2.38 | 2.39 |
| Cash Conversion Cycle | 182.65 | 272.00 | 273.28 | 166.00 |